This article explores the benefits of implementing RFID in healthcare settings and how hospitals can gradually transition from barcode to RFID-enabled medication systems, leading to substantial cost savings and improved patient care.

Lyfegen, a startup that provides software for value-based drug contracting, recently raised $8 million in an oversubscribed Series A financing round. With the new funds, the company — which is based in Switzerland and New York — plans to expand its presence in the U.S., where drug costs are the highest in the world.

Shkreli controversially raised the price of the drug Daraprim, which is used to treat a potentially fatal parasitic infection, by 4,000%, from $13.50 to $750 per pill in 2015. In January, a federal judge banned him from the pharmaceutical industry for life.

A new partnership between Amazon and First Databank will let users ask Alexa for basic information about the most commonly prescribed drugs.

Through its app, London-based Echo, which was founded in 2015, offers prescription fulfillment and reminders to take medications.

Various investors, including Stanley Black & Decker’s corporate venture capital arm, Samsung Ventures, Civilization Ventures and others took part in the round.

The Clearwater, Florida-based company said its HIPAA compliant telemedicine stations can be deployed in airports, hotels, colleges, hospitals and at large private employers.

Zola Global and Greenoaks Capital led the Series C round, and Jackson Square Ventures, Olive Tree Capital, and others participated.

The company will use the money to increase its pharmaceutical and pharmacy partnerships, expand into more healthcare verticals and enhance its data analysis and engineering applications.

The company’s Individual Risk Identification Score, or IRIS, uses machine learning to help hospitals pinpoint employees who pose a high risk for drug diversion.

The medical center implemented MedAware’s platform, which harnesses data analytics and machine learning to pinpoint prescription errors before they happen.

Rethink Impact led the Series A round, which will be used to grow Sempre’s relationships with health plans and to make its service available to more patients.

President Donald Trump has railed against the high price of prescription drugs, yet many Americans aren’t seeing a change in what they pay out-of-pocket. Here’s a look at the rhetoric thus far versus the results.

Named Mabu, Catalia’s interactive robot has tailored conversations with patients about their healthcare needs and relays progress information to their pharmacist or healthcare provider.

According to a Frost & Sullivan analysis, adverse patient safety events cost the U.S. and European healthcare systems $317.93 billion in 2016. By 2022, the analysis estimates that amount will rise to $383.7 billion.

In a recent phone interview, pharmacist Michael Rea explained why he founded Rx Savings Solutions, its goals for the year ahead and its $18.4 million funding round led by McCarthy Capital.

Topping this year’s list is ransomware and other cybersecurity threats. Contaminated mattresses, improperly cleaned medical devices and flaws in medical device networking also made the cut.

Minnetonka, Minnesota-based UnitedHealthcare has launched PreCheck MyScript, an online solution that simplifies the prescribing process and promotes better outcomes for physicians and patients.

For a limited time, the companies will provide pharmacists in Texas and Louisiana with free access to patient-specific medication history data.

Can using wireless technology, financial incentives and social support improve medication adherence in heart attack survivors? A recent study published in JAMA Internal Medicine dives in.